Duopa

Advanced Parkinson's Disease

Duopa is used to treat the symptoms of advanced Parkinson's disease, a condition that affects the nervous system and causes problems with movement. It is specifically intended for patients who experience motor fluctuations, often referred to as 'on-off' periods.

Common symptoms managed by this treatment include:

• Muscle stiffness and rigidity
• Tremors or shaking
• Slowness of movement
• Poor muscle control

Managing Motor Fluctuations

As Parkinson's disease progresses, oral medications may become less effective or cause unpredictable responses. Patients may find that their symptoms return quickly between doses of pills. Duopa is used in these situations to provide a more constant level of medication by delivering it directly into the small intestine. This helps to decrease the amount of 'off' time and increase the periods of time where symptoms are better controlled and movement is easier.

Restoring Dopamine Levels

Parkinson's disease occurs when the brain does not produce enough dopamine, a natural chemical that helps control muscle movement. Duopa contains two active ingredients, levodopa and carbidopa, that work together to address this deficiency.

• Levodopa: This is the primary medication. Once it reaches the brain, it is converted into dopamine to help improve motor function and reduce tremors or stiffness.
• Carbidopa: This ingredient prevents levodopa from breaking down in the bloodstream before it can reach the brain. By protecting the levodopa, carbidopa ensures more of the medicine is available for the brain to use and helps reduce side effects like nausea.

Continuous Delivery

Unlike traditional oral tablets, Duopa is an enteral suspension delivered directly into the small intestine through a portable pump. This method allows for a steady, continuous flow of medication throughout the day. By maintaining consistent levels of the drug in the body, Duopa helps minimize "off" periods, which are times when Parkinson's symptoms return as medication levels fluctuate.

Common Side Effects

• Nausea and vomiting
• Constipation
• Dizziness or lightheadedness
• Headache
• Dry mouth
• Trouble sleeping
• Increased sweating
• Anxiety

Serious Side Effects

• Uncontrollable or unusual body movements (dyskinesia)
• Hallucinations, confusion, or agitation
• Falling asleep suddenly during daily activities
• Severe depression or thoughts of self-harm
• Intense and uncontrollable urges, such as gambling or increased sexual activity
• Fainting or a sudden drop in blood pressure when standing
• Chest pain or shortness of breath
• Dark-colored urine or yellowing of the skin and eyes

Complications Related to the Infusion

Because this medication is delivered through a tube into the small intestine, side effects related to the surgical site or the device may occur. These include:

• Pain, redness, or swelling at the tube insertion site
• Infection at the site of the procedure
• Blockage, kinking, or movement of the infusion tube
• Stomach pain, bloating, or nausea related to the tube

Gastrointestinal and Procedure-Related Risks

Because Duopa is delivered through a surgically placed tube, serious gastrointestinal complications can occur. These may include:

• Stomach or intestinal blockage or perforation.
• Infection at the tube site (peritonitis).
• Bleeding or ulcers in the digestive tract.
• Tube dislocation or failure.

Sudden Onset of Sleep

Some people taking this medication have reported falling asleep suddenly during daily activities, including driving. This can occur without prior warning or feelings of drowsiness.

Psychiatric and Impulse Control Issues

Levodopa-containing medications may cause hallucinations, psychosis, or agitation. Some individuals experience intense urges to gamble, increased sexual urges, or binge eating while taking this medication. It is also associated with a risk of depression or suicidal thoughts.

Blood Pressure and Heart Health

Duopa can cause orthostatic hypotension, which is a sudden drop in blood pressure when standing up that may lead to dizziness or fainting. Caution is advised for those with a history of heart disease or recent heart attack.

Abrupt Discontinuation

Stopping Duopa suddenly or rapidly reducing the dose can lead to a serious condition similar to neuroleptic malignant syndrome. Symptoms may include high fever, muscle stiffness, and confusion.

Other Precautions

• Neuropathy: Some patients develop nerve damage (peripheral neuropathy) while using this medication.
• Glaucoma: Duopa may increase pressure in the eye. It is generally contraindicated in patients with narrow-angle glaucoma and requires monitoring in those with wide-angle glaucoma.
• Dyskinesia: Involuntary movements may occur or worsen, requiring a dosage adjustment.
• Vitamin Deficiencies: Long-term use may lead to low levels of certain B vitamins.
• Drug Interactions: Duopa should not be used by individuals who have taken a non-selective monoamine oxidase (MAO) inhibitor within the last 14 days.

Pregnancy

It is currently unknown whether Duopa can cause harm to an unborn baby. Research in animals has shown that the combination of carbidopa and levodopa can lead to developmental issues and structural abnormalities in the fetus. However, there are no well-controlled studies in pregnant humans to confirm these effects. Healthcare providers typically only recommend this medication during pregnancy if the potential benefits to the mother outweigh the potential risks to the fetus.

Breastfeeding

Levodopa, one of the active ingredients in Duopa, has been found to pass into human breast milk. Additionally, levodopa may interfere with the production of breast milk by reducing levels of prolactin, a hormone necessary for lactation. Because the effects on a nursing infant are not fully understood, caution is advised for those who are breastfeeding while using this medication.

Dosage Forms

Duopa is available as an enteral suspension. This liquid form of the medication is designed for continuous delivery into the small intestine rather than being swallowed as a pill.

The medication is packaged in single-use cassettes that are used with a portable infusion pump. The pump delivers the suspension through a tube that is surgically placed into the stomach and extended into the small intestine. This delivery method is intended to provide a steady level of medication throughout the day.

FDA Approval History

The U.S. Food and Drug Administration (FDA) approved Duopa (carbidopa and levodopa) enteral suspension in January 2015. It was developed to provide a continuous delivery of medication for patients with advanced Parkinson's disease who experience significant motor fluctuations that are not well-controlled by standard oral medications.

Approved Indications

Duopa is specifically indicated for the treatment of motor fluctuations in patients with advanced Parkinson's disease. It is designed to be administered over a 16-hour period using a portable infusion pump. The medication is delivered directly into the small intestine through a surgically placed tube, known as a percutaneous endoscopic gastrostomy with a jejunal tube (PEG-J).

Safety and Regulatory Oversight

• Boxed Warnings: Duopa does not currently carry any FDA boxed warnings.
• REMS: There is no Risk Evaluation and Mitigation Strategy (REMS) program required for this medication.
• Generic Availability: There is currently no FDA-approved generic version of Duopa enteral suspension available in the United States.

Because the administration of Duopa requires a surgical procedure to place the delivery tube, regulatory information also encompasses the safety and maintenance of the delivery system components, such as the pump and the intestinal tubing.

Generic Availability

There is currently no generic version of Duopa available. As a brand-name medication, it typically has a higher out-of-pocket cost than standard oral carbidopa-levodopa tablets.

Factors Affecting Total Cost

The total cost of treatment with Duopa involves several components beyond the medication itself:

• Medication Cassettes: The daily supply of carbidopa and levodopa enteral suspension.
• Surgical Procedure: The initial cost includes the placement of a PEG-J tube through which the medication is delivered.
• Infusion Pump: The portable pump required to administer the medication throughout the day.
• Maintenance: Costs associated with replacement tubing, pump supplies, and medical visits for dosage adjustments.

Insurance and Financial Assistance

Coverage for Duopa varies by provider and plan type. Because it involves both a drug and a delivery device, it may be covered under different parts of an insurance plan, such as medical benefits or pharmacy benefits. Medicare coverage may also vary depending on whether the medication is administered in a clinical setting or at home.

Many patients utilize manufacturer-sponsored patient assistance programs or co-pay cards to help manage costs. These programs are typically available to those who meet specific financial or insurance criteria.